Treatment of chronic hepatitis b with lamivudine in renal transplant recipients

Transplantation

Volumn 66, Issue 6, 1998, Pages 733-737

  Jung, Young Ok ^a   Lee, Yung Sang ^a   Yang, Won Seok ^a   Han, Duck Jong ^a   Park, Jung Sik ^a   Park, Su Kil ^a,b  

^a University of Ulsan   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; METHYLPREDNISOLONE SODIUM SUCCINATE; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; COMORBIDITY; DRUG EFFICACY; DRUG SAFETY; GRAFT REJECTION; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING; VIRUS INHIBITION;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; CREATININE; CYCLOSPORINE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LAMIVUDINE; MALE; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS REPLICATION;

EID: 0032572971     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199809270-00007     Document Type: Article

References (19)

1. Kane MA. Progress on the control of hepatitis B infection through immunisation. Gut 1993; 34 (suppl 2): S10
2. David CL, Gretch DR, Carithers RL Jr, et al. Hepatitis B and transplantation. Infect Dis Clin North Am 1995; 9: 925.
3. Kasiske BL, Ramos EL, Gaston RS, et al. The evaluation of renal transplant candidates: clinical practice guidelines. J Am Soc Nephrol 1995; 6: 1.
4. Parfrey PS, Forbes RD, Hutchinson TA, et al. The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 1985; 39: 610.
5. Pol S, Debure A, Degott C, et al. Chronic hepatitis in kidney allograft recipients. Lancet 1990; 335: 878.
6. Thomas HC, Scully LJ. Antiviral therapy in chronic hepatitis B infection. Br Med Bull 1985; 41: 374.
7. Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a metaanalysis. Ann Intern Med 1993; 119: 312.
8. Kramer P, ten Kate FW, Bijnen AB, Jeekel J, Weimar W. Recombinant leucocyte Interferon A induces steroid resistant acute vascular rejection episodes in renal transplant recipients. Lancet 1984; 1: 989.
9. Kovarik J, Mayer G, Pohanka E, et al. Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients: cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections. Transplantation 1988; 45: 402.
10. Therret E, Pol S, Legendre C, Gagnadoux MF, Cavalcanti R, Kreis M. Low-dose recombinant leucocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. Transplantation 1994; 58: 625.
11. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 1657.
12. Van Thiel DH, Friedlander L, Kania RJ, et al. Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B. Hepatogastroenterology 1997; 44: 808.
13. Ben-Ari Z, Shmueli D, Mor E, Shapira Z, Tur-Kaspa R. Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation. Transplantation 1997; 63: 393.
14. Bain VG, Kneteman NM, Ma MM, et al. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation 1996; 62: 1456.
15. Rostaing L, Henry S, Cisterne JM, Duffaut M, Icart J, Durand D. Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation. Transplantation 1997; 64: 1624.
16. Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 1993; 105: 274.
17. Peters M. Mechanism of action of interferons. Semin Liver Dis 1989; 9: 235.
18. Grellier L, Mutimer D, Ahmed M, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348: 1212.
19. Lai CL, Ching CK, Tung AK, et al. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology 1997; 25: 241.